Inflammaging: How Chronic Inflammation Accelerates the Aging Process

In 2000, Italian immunologist Claudio Franceschi coined the term "inflammaging" to describe a phenomenon that had been increasingly observed in aging research: as we get older, our baseline levels of inflammatory markers steadily rise, even in the absence of infection or injury. This chronic, sterile, low-grade inflammation appears to be one of the primary drivers of age-related disease and functional decline.

The concept has since become one of the most important frameworks in gerontology and has fundamentally changed how researchers think about aging itself.

What Causes Inflammaging?

Inflammaging is not caused by a single factor but by the convergence of multiple age-related processes:

Cellular senescence. As cells age, some enter a state called senescence: they stop dividing but do not die. Instead, they remain metabolically active and secrete a cocktail of inflammatory cytokines, chemokines, and matrix-degrading enzymes collectively known as the senescence-associated secretory phenotype (SASP). These "zombie cells" accumulate in tissues with age and create pockets of chronic inflammation that damage surrounding healthy tissue. Key SASP components include IL-6, IL-8, TNF-alpha, MCP-1, and matrix metalloproteinases that break down tissue structure.

Mitochondrial dysfunction. Mitochondria, the energy-producing organelles in cells, become less efficient with age. Damaged mitochondria release fragments of their own DNA (mtDNA) into the cell cytoplasm and circulation. Because mitochondrial DNA has bacterial origins, the immune system recognizes these fragments as foreign and mounts an inflammatory response through activation of the NLRP3 inflammasome and cGAS-STING pathway.

Gut barrier deterioration. The intestinal barrier becomes more permeable with age, a phenomenon sometimes called "leaky gut." This allows bacterial components, particularly lipopolysaccharide (LPS), to enter the bloodstream and activate systemic inflammatory responses. Age-related changes in the gut microbiome composition further exacerbate this process.

Immune system dysregulation (immunosenescence). The aging immune system undergoes significant changes: the thymus shrinks, reducing the production of new T-cells; remaining immune cells become more pro-inflammatory and less effective at fighting infections; and the balance between pro-inflammatory and anti-inflammatory immune responses shifts toward inflammation.

Telomeres, Epigenetics, and the Inflammation Clock

Two of the most studied biological markers of aging, telomere length and epigenetic clocks, are both intimately connected to inflammation.

Telomere shortening. Telomeres, the protective caps at the ends of chromosomes, shorten with each cell division and are considered a fundamental marker of cellular aging. Chronic inflammation accelerates telomere shortening through several mechanisms: oxidative stress from inflammatory ROS damages telomeric DNA, inflammatory cytokines increase cell division rates (shortening telomeres faster), and inflammation impairs telomerase, the enzyme that can partially restore telomere length. Studies have shown that individuals with higher CRP and IL-6 levels have significantly shorter telomeres than age-matched individuals with lower inflammatory markers.

Epigenetic aging. Epigenetic clocks, which measure biological age based on DNA methylation patterns, have revealed that chronic inflammation accelerates biological aging. A landmark study published in Nature Aging found that sustained elevated inflammatory markers were associated with epigenetic age acceleration of up to 5 years. This means that a 50-year-old with high chronic inflammation may have the epigenetic profile of a 55-year-old, with corresponding increases in age-related disease risk.

How Inflammaging Connects to Age-Related Disease

Inflammaging is the common thread running through most of the diseases we think of as simply "aging." The same low-grade inflammatory signaling that rises with age is an active driver of heart disease, where it fuels the plaque formation that narrows arteries. It contributes to the neuroinflammation implicated in cognitive decline, and it accelerates the loss of muscle known as sarcopenia and the thinning of bone that leaves older adults frail.

This is why researchers increasingly treat inflammation as a shared root rather than a separate problem for each organ. Rather than a dozen unrelated conditions arriving with age, many age-related diseases can be understood as different tissues failing under the same sustained inflammatory load. It reframes healthy longevity as, in large part, the project of keeping that load low, which is exactly what the centenarian data suggests.

Lessons from Centenarians

Some of the most compelling evidence for inflammaging comes from studies of centenarians, people who live to 100 or beyond. These individuals have consistently shown distinctive inflammatory profiles that set them apart from the general aging population:

• Lower baseline inflammatory markers: Despite their advanced age, centenarians typically have lower CRP, IL-6, and TNF-alpha levels than much younger individuals who develop age-related diseases. Their inflammatory markers are often comparable to people 20 to 30 years younger.
• Higher anti-inflammatory capacity: Centenarians tend to have higher levels of anti-inflammatory cytokines (IL-10, TGF-beta) and more efficient inflammation resolution mechanisms. Their immune systems appear better at terminating inflammatory responses once the threat has passed.
• Genetic factors: Studies of centenarian families have identified genetic variants in inflammatory pathway genes (particularly in IL-6, TNF-alpha, and IL-10 gene promoters) that are associated with lower inflammatory responses. These findings suggest that the ability to control inflammation is partly heritable and contributes significantly to exceptional longevity.
• Preserved gut barrier function: Centenarians tend to maintain better intestinal barrier integrity and more diverse gut microbiomes than typical older adults, resulting in lower levels of bacterial translocation and associated inflammation.

The centenarian research delivers a clear message: it is not the absence of aging that promotes longevity, but the ability to age without excessive inflammation.

Slowing Inflammaging: Evidence-Based Strategies

While we cannot stop aging, the research strongly suggests that we can significantly influence the rate of inflammaging through modifiable factors:

1. Caloric moderation and time-restricted eating. Caloric restriction is one of the most robust interventions for reducing inflammaging in animal studies, and emerging human data supports similar benefits. Even modest caloric reduction (10 to 15 percent) has been shown to reduce CRP, TNF-alpha, and other inflammatory markers. Time-restricted eating (limiting food intake to a 10 to 12 hour window) may provide similar benefits by reducing metabolic stress and improving autophagy, the cellular cleanup process that removes damaged mitochondria and senescent cells.
2. Regular moderate exercise. Exercise is one of the most potent anti-inflammaging interventions available. It reduces senescent cell burden, improves mitochondrial function, strengthens the gut barrier, and modulates immune function toward an anti-inflammatory profile. Studies consistently show that physically active older adults have inflammatory profiles resembling those of people decades younger.
3. Prioritize sleep quality. Sleep is when the brain's glymphatic system clears inflammatory debris, damaged cells undergo autophagy, and the immune system rebalances. Chronic sleep disruption accelerates every driver of inflammaging.
4. Support gut health. A diverse, fiber-rich diet feeds beneficial gut bacteria that produce short-chain fatty acids (SCFAs), particularly butyrate, which strengthen the gut barrier and have direct anti-inflammatory effects. Fermented foods (yogurt, kefir, sauerkraut, kimchi) provide beneficial bacteria that can help maintain microbial diversity with age.
5. Monitor and track inflammation. You cannot manage what you do not measure. Regular assessment of inflammatory biomarkers provides objective data on whether your anti-inflammaging strategies are working. Tracking trends over months and years is far more valuable than any single measurement.

Tracking Inflammaging Over Time

Inflammaging is a slow trend, which makes it uniquely suited to long-term tracking. Unlike an acute illness, the rise in baseline inflammation plays out over years, so a single lab value tells you little about the trajectory that actually matters. What is informative is the direction of your inflammatory markers over months and years, and whether the levers you are pulling, exercise, sleep, gut health, and caloric moderation, are bending that curve downward.

C-reactive protein is the most practical marker for this because it reflects the same IL-6-driven signaling that defines inflammaging. Sensa is designed to make tracking it simple, letting you check CRP at home without a needle or a clinic visit, so a measurement becomes a routine data point rather than a rare event. Watching your CRP trend hold low or drift downward as you age is a tangible signal that you are aging closer to the centenarian pattern than the disease pattern, and it lets you catch an upward drift early, while lifestyle changes can still bend it back. CRP is a general wellness marker rather than a diagnosis, so persistent elevations are worth discussing with a healthcare provider.

Inflammaging represents one of the most actionable frontiers in aging science. While your chronological age is fixed, your biological age and the inflammatory processes that drive it are remarkably responsive to intervention.